STAT5a/b contribute to sex bias in vascular disease: A neuroendocrine perspective

REFERENCES

• Xing D, Nozell S, Chen YF, Hage F, Oparil S. Estrogen and mechanisms of vascular protection. Anterioscler Thromb Vasc Biol 2009; 29:289-95; http://dx.doi.org/10.1161/ATVBAHA.108.182279
   PubMed Web of Science ®Google Scholar
• Pepine CJ, Nichols WW, Pauly DF. Estrogen and different aspects of vascular disease in women and men. Cir Res 2006; 99:459-61; PMID: 26252185; 10.2119/molmed.2015.00122
   PubMed Web of Science ®Google Scholar
• Tuder RM, Marecki JC, Richter A, Fijlkowska I, Flores S. Pathology of pulmonary hypertension. Clin Chest Med 2007; 28:23-42; PMID:17338926; http://dx.doi.org/10.1016/j.ccm.2006.11.010
   PubMed Web of Science ®Google Scholar
• Rabinovitch M. Molecular pathogenesis of pulmonary hypertension. J Clin Invest 2008; 118:2372-9; PMID:18596905; http://dx.doi.org/10.1172/JCI33452
   PubMed Web of Science ®Google Scholar
• Austin ED, Cogan JD, West JD, Hedges LK, Hamid R, Dawson EP, Wheeler LA, Parl FF, Loyd JE, Phillips JA, 3rd. Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females. Eur Respir J 2009; 34:1093-9; PMID:19357154; http://dx.doi.org/10.1183/09031936.00010409
   PubMed Web of Science ®Google Scholar
• Lahm T, Tuder R, Petrache I. Progress in solving the sex hormone paradox in pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2014; 307:L7-L26; PMID:24816487; http://dx.doi.org/10.1152/ajplung.00337.2013
   PubMedGoogle Scholar
• Kumar A, Lindner V. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterio Thromb Vasc Biol 1997; 17:2238-44; http://dx.doi.org/10.1161/01.ATV.17.10.2238
   PubMed Web of Science ®Google Scholar
• Boucher JM, Harrington A, Rostama B, Lindner V, Liaw L. A receptor-specific function for Notch2 in mediating vascular smooth muscle cell growth arrest through p27kip1. Circ Res 2013; 113:975-85; PMID:23965337; http://dx.doi.org/10.1161/CIRCRESAHA.113.301272
   PubMed Web of Science ®Google Scholar
• Kumar A, Hoover JL, Simmons CA, Lindner V, Shebuski RJ. Remodeling and neointimal formation in the carotid artery of normal and P-selectin-deficient mice. Circulation 1997; 96:4333-42; PMID:9416901; http://dx.doi.org/10.1161/01.CIR.96.12.4333
   PubMed Web of Science ®Google Scholar
• Vermeersch P, Buys Em, Sips P, Pokreisz P, Marsboom G, Gillijns H, Pellens M, Dewerchin M, Bloch KD, Brouckaert P, et al. Gender-specific modulation of the response to arterial injury by soluble guanylate cyclase α1. Open Cardio Med J 2009; 3:98-104; http://dx.doi.org/10.2174/1874192400903010098
   PubMedGoogle Scholar
• Sullivan TR, Jr, Karas RH, Aronovitz M, Faller GT, Ziar JP, Smith JJ, O'Donnell TF, Jr, Mendelsohn ME. Estrogen inhibits the response-to-injury in a mouse carotid artery model. J Clin Invest 1995; 96:2482-8; PMID:7593638; http://dx.doi.org/10.1172/JCI118307
   PubMed Web of Science ®Google Scholar
• Savolainen-Peltonen H, Luoto NM, Kangas L, Häyry P. Selective estrogen receptor modulators prevent neointima formation after vascular injury. Mol Cell Endocrinol 2004; 227:9-20; PMID:15501580; http://dx.doi.org/10.1016/j.mce.2004.08.004
   PubMed Web of Science ®Google Scholar
• Akishita M, Ouchi Y, Miyoshi H, Kozaki K, Inoue S, Ishikawa M, Eto M, Toba K, Orimo H. Estrogen inhibits cuff-induced initimal thickening of rat femoral artery: effects on migration and proliferation of vascular smooth muscle cells. Altherosclerosis 1997; 130:1-10; http://dx.doi.org/10.1016/S0021-9150(96)06023-6
   PubMed Web of Science ®Google Scholar
• Malorni W, Straface E, Matarrese P, Ascione B, Coinu R, Canu S, Galluzzo P, Marino M, Franconi F. Redox state and gender differences in vascular smooth muscle cells. FEBS Letters 2008; 582:635-42; PMID:18242172; http://dx.doi.org/10.1016/j.febslet.2008.01.034
   PubMed Web of Science ®Google Scholar
• Hogg ME, Vavra AK, Banerjee MN, Martinez J, Jiang Q, Keefer LK, Chambon P, Kibbe MR. The role of estrogen receptor α and β in regulating vascular smooth muscle cell proliferation is based on sex. J Surg Res 2012; 173:1-10; PMID:21658718; http://dx.doi.org/10.1016/j.jss.2011.09.021
   PubMed Web of Science ®Google Scholar
• Mair KM, Johansen AKZ, Wright AF, Wallace E, MacLean MR. Pulmonary arterial hypertension: basis of sex differences in incidence and treatment response. Brit J Pharmacol 2014; 171:567-79; http://dx.doi.org/10.1111/bph.12281
   PubMed Web of Science ®Google Scholar
• Umar S, Rabinovitch M, Eghbali M. Estrogen paradox in pulmonary hypertension – current controversies and future perspectives. Am J Respir Crit Care Med 2012; 186:125-31; PMID:22561960; http://dx.doi.org/10.1164/rccm.201201-0058PP
   PubMed Web of Science ®Google Scholar
• Liu A, Schreier D, Tian L, Eickhoff JC, Wang Z, Hacker TA, Chesler NC. Direct and indirect protection of right ventricular function by estrogen in an experimental model of pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol 2014; 307:H273-83; PMID:24906919; http://dx.doi.org/10.1152/ajpheart.00758.2013
   PubMedGoogle Scholar
• Frump AL, Goss KN, Vayl A, Albrecht M, Fisher A, Tursunova R, Fierst J, Whitson J, Cucci AR, Brown MB, Lahm T. Estradiol improves right ventricular function in rats with severe angioproliferative pulmonary hypertension: effects of endogenous and exogenous sex hormones. Am J Physiol Lung Cell Mol Physiol 2015; 308:L873-90; PMID:25713318; http://dx.doi.org/10.1152/ajplung.00006.2015
   PubMedGoogle Scholar
• Sehgal PB, Yang YM, Miller EJ. Hypothesis: neuroendocrine mechanisms (hypothalamus-growth hormone-STAT5 axis) contribute to sex nias in pulmonary hypertension. Mol Med 2015; Epub July 30; http://dx.doi.org/10.2119/molmed.2015.00122; PMID: 26252185
   Google Scholar
• Montague CR, Hunter MG, Cavrilin MA, Phillips GS, Goldschmidt-Clermont PJ, Marsh CB. Activation of estrogen receptor-α-reduces aortic smooth muscle differentiation. Cir Res 2006; 99:477-84; http://dx.doi.org/10.1161/01.RES.0000238376.72592.a2
   PubMed Web of Science ®Google Scholar
• Ueda K, Lu Q, Baur W, Aronovitz MJ, Karas RH. Rapid estrogen receptor signaling mediates estrogen-induced inhibition of vascular smooth muscle cell proliferation. Anterioscler Thromb Vasc Biol 2013; 33:1837-43; http://dx.doi.org/10.1161/ATVBAHA.112.300752
   PubMed Web of Science ®Google Scholar
• Bernelot Meons SJ, Schnitzler GR, Nickerson M, Guo H, Ueda K, Lu Q, Aronovitz MJ, Nickerson H, Bauer WE, Hansen U, et al. Rapid estrogen receptor signaling is essential for the protective effects of estrogen against vascular injury. Circulation 2012; 126:1993-2004; PMID:22997253; http://dx.doi.org/10.1161/CIRCULATIONAHA.112.124529
   PubMed Web of Science ®Google Scholar
• Kappert K, Caglayan E, Hunteburth M, Bäumer AT, Sparwel J, Uebel M, Rosenkranz S. 17beta-estradiol attenuates PDGF signaling in vascular smooth muscle cells at the postreceptor level. Am J Physiol Heart Circ Physiol 2006; 290:H538-46; PMID:16227346; http://dx.doi.org/10.1152/ajpheart.00240.2005
   PubMed Web of Science ®Google Scholar
• Austin ED, Hamid R, Hemnes AR, Loyd JE, Blackwell T, Yu C, Phillips JA III, Gaddipati R, Gladson S, Gu E, et al. BMPR2 expression is suppressed by signaling through the estrogen receptor. Biol Sex Differences 2012; 3:6; http://dx.doi.org/10.1186/2042-6410-3-6
   PubMed Web of Science ®Google Scholar
• Fessel JP, Chen X, Frump A, Gladson S, Blackwell T, Kang C, Johnson J, Loyd JE, Hemnes A, Austin E, et al. Interaction between bone morphogenetic protein receptor type 2 and estrogeneic compounds in pulmonary arterial hypertension. Pulm Circ 2013; 3:564-77; PMID:24618541; http://dx.doi.org/10.1086/674312
   PubMedGoogle Scholar
• Mair KM, Yang XD, Long L, White K, Wallace E, Ewart MA, Docherty CK, Morrell NW, MacLean MR. Sex affects BMPR-II signaling in pulmonary artery smooth muscle cells. Am J Respir Crit Care Med 2015; 191:693-703; PMID:25608111; http://dx.doi.org/10.1164/rccm.201410-1802OC
   PubMed Web of Science ®Google Scholar
• Wright AF, Ewart MA, Mair K, Nilsen M, Dempsie Y, Loughlin L, Maclean MR. Oestrogen receptor α in pulmonary hypertension. Cardiovasc Res 2015; 106:206-16; PMID:25765937; http://dx.doi.org/10.1093/cvr/cvv106
   PubMed Web of Science ®Google Scholar
• Waxman DJ, Holloway MG. Sex differences in the expression of hepatic drug metabolizing enzymes. Mol Pharmacol 2009; 76:215-28; PMID:19483103; http://dx.doi.org/10.1124/mol.109.056705
   PubMed Web of Science ®Google Scholar
• Dhir RN, Shapiro BH. Interpulse growth hormone secretion in the episodic plasma profile causes the sex reversal of cytochrome P450s in senescent mate rats. Proc Natl Acad Sci USA 2003; 100:15224-8; PMID:14638941; http://dx.doi.org/10.1073/pnas.2434273100
   PubMed Web of Science ®Google Scholar
• Waxman DJ, Ram PA, Pampori NA, Shapiro BH. Growth hormone regulation of male-specific rat liver P450s 2A2 and 3A2: induction by intermittent growth hormone pulses in male but not in female rats rendered growth hormone deficient by neonatal monosodium glutamate. Mol Pharmacol 1995; 48:790-7; PMID:7476908
   PubMed Web of Science ®Google Scholar
• Thangavel C, Garcia MC, Shapiro BH. Intrinsic sex differences determine expression of growth hormone-regulated female cytochrome P450s. Mol Cell Endocrinol 2004; 220:31-9; PMID:15196697; http://dx.doi.org/10.1016/j.mce.2004.04.002
   PubMed Web of Science ®Google Scholar
• Thangavel C, Dworakowski W, Shapiro BH. Inducibility of male-specific isoforms of cytochrome P450 by sex-dependent growth hormone profiles in hepatocyte cultures from male but not female rats. Drug Metab Dispos 2006; 34:410-9; PMID:16339352
   PubMed Web of Science ®Google Scholar
• Martignoni M, Groothuis GMM, Kanter R. Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol 2006; 2:875-94; PMID:17125407; http://dx.doi.org/10.1517/17425255.2.6.875
   PubMed Web of Science ®Google Scholar
• Cheung C, Yu AM, Chen CS, Krausz KW, Byrd LG, Feigenbaum L, Edwards RJ, Waxman DJ, Gonzalez FJ. Growth hormone determines sexual dimorphism of hepatic cytochrome P450 3A4 expression in transgenic mice. J Pharmacol Exptl Ther 2006; 316:1328-34; http://dx.doi.org/10.1124/jpet.105.094367
   PubMed Web of Science ®Google Scholar
• Kato R, Onoda K. Studies on the regulation of the activity of drug oxidation in rat liver microsomes by androgen and estrogen. Biochem Pharmacol 1970; 19:1649-60; PMID:4398016; http://dx.doi.org/10.1016/0006-2952(70)90328-X
   PubMed Web of Science ®Google Scholar
• Colby HD, Gaskin JH, Kitay JI. Requirement of the pituitary gland for gonadal hormone effects on hepatic corticosteroid metabolism in rats and hamsters. Endocrinol 1973; 92:769-74; http://dx.doi.org/10.1210/endo-92-3-769
   PubMed Web of Science ®Google Scholar
• Kramer RE, Greiner JW, Rumbaugh RC, Sweeney TD, Colby HD. Requirement of the pituitary gland for gonadal hormone effects on hepatic drug metabolism in rats. J Pharmacol Exptl Ther 1979; 208:19-23
   PubMed Web of Science ®Google Scholar
• Rumbaugh RC, Colby HD. Is growth hormone the pituitary feminizing factor mediating the actions of estradiol on hepatic drug and steroid metabolism? Endocrinol 1980; 107:719-24; http://dx.doi.org/10.1210/endo-107-3-719
   PubMed Web of Science ®Google Scholar
• Sakuma T, Endo Y, Mashino M, Kuroiwa M, Ohara A, Jarukamjorn K, Nemoto N. Regulation of the expression of two female-predominant CYP3A mRNAs (CYP3A1 and CYP3A44) in mouse liver by sex and growth hormone. Arch Biochem Biophys 2002; 404:234-42; PMID:12147261; http://dx.doi.org/10.1016/S0003-9861(02)00329-6
   PubMed Web of Science ®Google Scholar
• Muller EE, Locatelli V, Cocchi D. Neuroendocrine control of growth hormone secretion. Physiol Rev 1999; 79:511-607; PMID:10221989
   PubMed Web of Science ®Google Scholar
• Nishida Y, Yoshioka M, St. Amand J. Sexually dimorphic gene expression in the hypothalamus, pituitary gland, and cortex. Genomics 2005; 85:679-87; PMID:15885495; http://dx.doi.org/10.1016/j.ygeno.2005.02.013
   PubMed Web of Science ®Google Scholar
• MacLeod JN, Pampori NA, Shapiro BH. Sex differences in the ultradian pattern of plasma growth hormone concentrations in mice. J Endocrinol 1991; 131:395-9; PMID:1783886; http://dx.doi.org/10.1677/joe.0.1310395
   PubMed Web of Science ®Google Scholar
• Low MJ, Otero-Corchon V, Parlow AF, Ramirez JL, Kumar U, Patel YC, Rubinstein M. Somatostatin is required for masculinization of growth hormone-regulated hepatic gene expression but not of somatic growth. J Clin Invest 2001; 107:1571-80; PMID:11413165; http://dx.doi.org/10.1172/JCI11941
   PubMed Web of Science ®Google Scholar
• Coutant R, Lahlou N, Bouvattier C, Bougneres P. Circulating leptin level and growth hormone response to stimulation in obese and normal children. Eur J Endocrinol 1998; 139:591-7; PMID:9916863; http://dx.doi.org/10.1530/eje.0.1390591
   PubMed Web of Science ®Google Scholar
• Waxman DJ, Ram PA, Park SH, Choi HK. Intermittant plasma growth hormone triggers tyrosine phosphorylation and nuclear translocation of a liver-expressed, Stat 5-related DNA binding protein: proposed role as an intracellular regulator of male-specific liver gene transcription. J Biol Chem 1995; 27:13262-70; http://dx.doi.org/10.1074/jbc.270.22.13262
   Google Scholar
• Gebert CA, Park SH, Waxman DJ. Regulation of signal transducer and activator of transcription (STAT) 5b activation by the temporal pattern of growth hormone stimulation. Mol Endocrinol 1997; 11:400-14; PMID:9092792; http://dx.doi.org/10.1210/mend.11.4.9904
   PubMed Web of Science ®Google Scholar
• Tannenbaum GS, Choi HK, Gurd W, Waxman DJ. Temporal relationship between the sexually dimorphic spontaneous GH secretory profiles and hepatic STAT5 activity. Endocrinol 2001; 142:4599-606; http://dx.doi.org/10.1210/endo.142.11.8480
   PubMed Web of Science ®Google Scholar
• Garcia-Segura LM, Baetens D, Naftolin F. Synaptic remodeling in arcuate nucleus after injection of estradiol valerate in adult female rats. Brain Res 1986; 366:131-6; PMID:3697673; http://dx.doi.org/10.1016/0006-8993(86)91287-4
   PubMed Web of Science ®Google Scholar
• Shirasu K, Stumpf WE, Sar M. Evidence for direct action of estradiol on growth hormone-releasing factor (GRF) in rat hypothalamus: localization of [3H]estradiol in GRF neurons. Endocrinol 1990; 127:344-9; http://dx.doi.org/10.1210/endo-127-1-344
   PubMed Web of Science ®Google Scholar
• Senaris RM, Lago F, Lewis MD, Dominguez F, Scanlon MF, Dieguez C. Differential effects of in vivo estrogen administration on hypothalamic growth hormone releasing hormone and somatostatin gene expression. Neurosci Lett 1992; 141:123-6; PMID:1354846; http://dx.doi.org/10.1016/0304-3940(92)90349-C
   PubMed Web of Science ®Google Scholar
• Desjardins GC, Brawer JR, Beaudet A. Estradiol is selectively neurotoxic to hypothalamic β-endorphin neurons. Endocrinol 1993; 132:86-93
   PubMed Web of Science ®Google Scholar
• Brawer JR, Beaudet A, Desjardins GC, Schiffer HM. Pathologic effect of estradiol on the hypothalamus. Biol Reprod 1993; 49:647-52; PMID:8218628; http://dx.doi.org/10.1095/biolreprod49.4.647
   PubMed Web of Science ®Google Scholar
• Kelly MJ, Ronnekleiv OK. Neural signaling of estradiol in the hypothalamus. Mol Endocrinol 2015; 29(5):645-57; PMID:25751314; http://dx.doi.org/10.1210/me.2014-1397
   PubMed Web of Science ®Google Scholar
• Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, Ram PA, Waxman DJ, Davey HW. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci USA 1997; 94:7239-44; PMID:9207075; http://dx.doi.org/10.1073/pnas.94.14.7239
   PubMed Web of Science ®Google Scholar
• Holloway MG, Cui Y, Laz EV, Hosui A, Hennighausen L, Waxman DJ. Loss of sexually dimorphic liver gene expression upon hepatocyte-specific deletion of Stat5a-Stat5b locus. Endocrinol 2007; 148:1977-86; http://dx.doi.org/10.1210/en.2006-1419
   PubMed Web of Science ®Google Scholar
• Zhang Y, Laz EV, Waxman DJ. Dynamic, sex-differential STAT5 and BCL6 binding to sex-biased, growth hormone-regulated genes in adult mouse liver. Mol Cell Biol 2012; 32:880-96; PMID:22158971; http://dx.doi.org/10.1128/MCB.06312-11
   PubMed Web of Science ®Google Scholar
• Meyer RD, Laz EV, Su T, Waxman DJ. Male-specific hepatic Bcl6: Growth hormone-induced block of transcription elongation in females and binding to target genes inversely coordinated with STAT5. Mol Endocrinol 2009; 23:1914-26; PMID:19797429; http://dx.doi.org/10.1210/me.2009-0242
   PubMed Web of Science ®Google Scholar
• Sugathan A, Waxman DJ. Genome-wide analysis of chromatin states reveals distinct mechanisms of sex-dependent gene regulation in male and female mouse liver. Mol Cell Biol 2013; 33:3594-610; PMID:23836885; http://dx.doi.org/10.1128/MCB.00280-13
   PubMed Web of Science ®Google Scholar
• Edén S. Age- and sex-related differences in episodic growth hormone secretion in the rat. Endocrinol 1979; 105:555-60; http://dx.doi.org/10.1210/endo-105-2-555
   PubMed Web of Science ®Google Scholar
• Winer LM, Shaw MA, Baumann G. Basal plasma growth hormone levels in man: new evidence for rhythmicity of growth hormone secretion. J Clin Endocrinol Metab 1990; 70:1678-86; PMID:2347901; http://dx.doi.org/10.1210/jcem-70-6-1678
   PubMed Web of Science ®Google Scholar
• MacLeod JN, Pampori NA, Shapiro BH. Sex differences in the ultradian pattern of plasma growth hormone concentrations in mice. J Endocrinol 1991; 131:395-9; PMID:1783886; http://dx.doi.org/10.1677/joe.0.1310395
   PubMed Web of Science ®Google Scholar
• Painson JC, Tannenbaum GS. Sexual dimorphism of stomatostatin and growth hormone-releasing factor signaling in the control of pulsatile growth hormone secretion in the rat. Endocrinol 1991; 128:2858-66; http://dx.doi.org/10.1210/endo-128-6-2858
   PubMed Web of Science ®Google Scholar
• van den Berg G, Veldhuis JD, Frolich M, Roelfsema F. An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender differences in mean GH concentrations in men and premenopausal women. J Clin Endocrinol Metab 1996; 81:2460-7; PMID:8675561
   PubMed Web of Science ®Google Scholar
• Pincus SM, Gevers EF, Robinson IC, van den Berg G, Roelfsema F, Hartman ML, Veldhuis JD. Females secrete growth hormone with more process irregularity than males in both humans and rats. Am J Physiol 1996; 270:E107-15; PMID:8772482
   PubMedGoogle Scholar
• Engström BE, Karlsson FA, Wide L. Marked gender differences in ambulatory morning growth hormone values in young adults. Clin Chem 1998; 44:1289-95; PMID:9625055
   PubMed Web of Science ®Google Scholar
• Waxman DJ, O'Connor C. Growth hormone regulation of sex-dependent liver gene expression. Molec Endocrinol 2006; 20:2613-29; http://dx.doi.org/10.1210/me.2006-0007
   PubMed Web of Science ®Google Scholar
• Subramanian A, Teixeira J, Wang J, Gil G. A STAT factor mediates the sexually dimorphic regulation of hepatic cytochrome P450 3A10/lithocholic acid 6 β-hydroxylase gene expression by growth hormone. Mol Cell Biol 1995; 15:4672-82; PMID:7651384
   PubMed Web of Science ®Google Scholar
• Kasahara Y, Kiyatake K, Tatsumi K, Sugito K, Kakusaka I, Yamagata S, Ohmori S, Kitada M, Kuriyama T. Bioactivation of monocrotaline by P-450 3A in rat liver. J Cardiovasc Pharmacol 1997; 30:124-9; PMID:9268231; http://dx.doi.org/10.1097/00005344-199707000-00018
   PubMed Web of Science ®Google Scholar
• Reid MJ, Lame MW, Morin D, Wilson DW, Segall HJ. Involvement of cytochrome P450 3A in the metabolism and covalent binding of 14C-monocrotaline in rat liver microsomes. J Biochem Mol Toxicol 1998; 12:157-66; PMID:9522275; http://dx.doi.org/10.1002/(SICI)1099-0461(1998)12:3%3c157::AID-JBT4%3e3.0.CO;2-K
   PubMed Web of Science ®Google Scholar
• Paukku K, Valgeirsdóttir S, Saharinen P, Bergman M, Heldin CH, Silvennoinen O. Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF β-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases. Biochem J 2000; 345:759-66; PMID:10642538; http://dx.doi.org/10.1042/bj3450759
   PubMed Web of Science ®Google Scholar
• Cao H, Dronadula N, Rizvi F, Li Q, Srivastava K, Gerthoffer WT, Rao GN. Novel role for STAT-5B in the regulation of Hsp27-FGF-2 axis facilitating thrombin-induced vascular smooth muscle cell growth and motility. Cir. Res 2006; 98:913-22.
   Google Scholar
• Kundumani-Shridharan V, Wang D, Karpurapu M, Liu Z, Zhang C, Dronadula N, Rao GN. Suppression of activation of signal transducer and activator of transcription-5B signaling in the vessel wall reduces balloon injury-induced neointima formation. Am J Pathol 2007; 171:1381-94; PMID:17823285; http://dx.doi.org/10.2353/ajpath.2007.061258
   PubMed Web of Science ®Google Scholar
• Han M, Li AY, Meng F, Dong LH, Zheng B, Hu HJ, Nie L, Wen JK. Synergistic co-operation of signal transducer and activator of transcription 5B with activator protein 1 in angiotensin IIK-induced angiotensinogen gene activation in vascular smooth muscle cells. FEBS J 2009; 276:1720-8; PMID:19220857; http://dx.doi.org/10.1111/j.1742-4658.2009.06902.x
   PubMed Web of Science ®Google Scholar
• Tiell ML, Stemerman MB, Spaet TH. The influence of the pituitary on arterial intimal proliferation in the rat. Circ Res 1978; 42:644-9; PMID:639188; http://dx.doi.org/10.1161/01.RES.42.5.644
   PubMed Web of Science ®Google Scholar
• Khorsandi M, Fagin JA, Fishbein MC, Forrester JS, Cercek B. Effects of hypophysectomy on vascular insulin-like growth factor-I gene expression after balloon denudation in rats. Atherosclerosis 1992; 93:115-22; PMID:1596294; http://dx.doi.org/10.1016/0021-9150(92)90205-U
   PubMed Web of Science ®Google Scholar
• Isgaard J, Arcopinto M, Karason K, Cittadini A. GH and the cardiovascular system: an update on a topic at heart. Endocrine 2015; 48:25-35; PMID:24972804; http://dx.doi.org/10.1007/s12020-014-0327-6
   PubMed Web of Science ®Google Scholar
• Jin MH, Yokoyama U, Sato Y, Shioda A, Jiao Q, Ishikawa Y, Minamisawa S. DNA microarray profiling identified a new role of growth hormone in vascular remodeling of rat ductus arteriosus. J Physiol Sci 2011; 61:167-79; PMID:21287305; http://dx.doi.org/10.1007/s12576-011-0133-3
   PubMed Web of Science ®Google Scholar
• Capaldo B, Guardasole V, Pardo F, Matarazzo M, Di  , Rella F, Numis F, Merola B, Longobardi S, Saccà L. Abnormal vascular reactivity in growth hormone deficiency. Circulation 2001; 103:520-4; PMID:11157716; http://dx.doi.org/10.1161/01.CIR.103.4.520
   PubMed Web of Science ®Google Scholar
• Borson-Chazot F, Serusclat A, Kalfallah Y, Ducottet X, Sassolas G, Bernard S, Labrousse F, Pastene J, Sassolas A, Roux Y, Berthezène F. Decrease of carotid intima-media thickness after one year growth hormone (GH) treatment in adults with GH deficiency. J Clin Endocrin Metabol 1999; 84:1329-33
   PubMed Web of Science ®Google Scholar
• Lee JE, Yang YM, Liang FX, Gough DJ, Levy DE, Sehgal PB. Nongenomic STAT5-dependent effects on Golgi apparatus and endoplasmic reticulum structure and function. Am J Physiol Cell Physiol 2012; 302:C804-20; PMID:22159083; http://dx.doi.org/10.1152/ajpcell.00379.2011
   PubMedGoogle Scholar
• Yang YM, Lane KB, Sehgal PB. Subcellular mechanisms in pulmonary arterial hypertension: combinatorial modalities that inhibit anterograde trafficking and cause BMPR2 mislocalization. Pulm Circ 2013; 3:533-50; PMID:24618539; http://dx.doi.org/10.1086/674336
   PubMedGoogle Scholar
• Yang YM, Yuan H, Edwards JG, Skayian Y, Ochani K, Miller EJ, Sehgal PB. Deletion of STAT5a/b in vascular smooth muscle abrogates the male bias in hypoxic pulmonary hypertension in mice: implications in the human disease. Mol Med 2014; 20:625-38.
   Web of Science ®Google Scholar
• Joung YH, Park JH, Park T, Lee CS, Kim OH, Ye SK, Yang UM, Lee KJ, Yang YM. Hypoxia activates signal transducers and activators of transcription 5 (STAT5) and increases its binding activity to the GAS element in mammary epithelial cells. Exp Mol Med 2003; 35:350-7; PMID:14646587; http://dx.doi.org/10.1038/emm.2003.46
   PubMed Web of Science ®Google Scholar
• Sehgal PB, Mukhopadhyay S, Patel K, Xu F, Almodóvar S, Tuder RM, Flores SC. Golgi dysfunction is a common feature in idiopathic human pulmonary hypertension and vascular lesions in SHIV-nef-infected macaques. Am J Physiol Lung Cell Mol Physiol 2009; 297:L729-37; PMID:19648286; http://dx.doi.org/10.1152/ajplung.00087.2009
   PubMed Web of Science ®Google Scholar
• Dent AL, Shaffer AL, Yu X, Allman D, Staudt LM. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 1997; 276:589-92; PMID:9110977; http://dx.doi.org/10.1126/science.276.5312.589
   PubMed Web of Science ®Google Scholar
• Toney LM, Cattoretti G, Graf JA, Merghoub T, Pandolfi PP, Dalla-Favera R, Ye BH, Dent AL. BCL-6 regulates chemokine gene transcription in macrophages. Nat Immunol 2000; 1:214-20; PMID:10973278 http://dx.doi.org/10.1038/79749
   PubMed Web of Science ®Google Scholar
• Liao W, Spolski R, Li P, Du N, West EE, Ren M, Mitra S, Leonard WJ. Opposing actions of IL-2 and IL-21 on Th9 differentiation correlates with their differential regulation of BCL6 expression. Proc Natl Acad Sci USA 2014; 111:3508-13; PMID:24550509; http://dx.doi.org/10.1073/pnas.1301138111
   PubMed Web of Science ®Google Scholar
• Burke DL, Frid MG, Kunrath CL, Karoor V, Anwar A, Wagner BD, Strassheim D, Stenmark KR. Sustained hypoxia promotes the development of a pulmonary artery-specific inflammatory microenvironment. Am J Physiol Lung Cell Mol Physiol 2009; 297:L238-50; PMID:19465514; http://dx.doi.org/10.1152/ajplung.90591.2008
   PubMedGoogle Scholar
• Soon E, Holmes AM, Treacy CM, Doughty NJ, Southgate L, Machado RD, Trembath RC, Jennings S, Barker L, Nicklin P, et al. Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation 2010; 122:920-7; PMID:20713898; http://dx.doi.org/10.1161/CIRCULATIONAHA.109.933762
   PubMed Web of Science ®Google Scholar
• Daley E, Emson C, Guignabert C, de Waal Malefyt R, Louten J, Kurup VP, Hogaboam C, Taraseviciene-Stewart L, Voelkel NF, Rabinovitch M, et al. Pulmonary arterial remodeling induced by a Th2 immune response. J Exp Med 2008; 205:361-72; PMID:18227220; http://dx.doi.org/10.1084/jem.20071008
   PubMed Web of Science ®Google Scholar
• Savai R, Al-Tamari HM, Sedding D, Kojonazarov B, Muecke C, Teske R, Capecchi MR, Weissmann N, Grimminger F, Seeger W, et al. Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension. Nat Med 2014; 20:1289-300; PMID:25344740; http://dx.doi.org/10.1038/nm.3695
   PubMed Web of Science ®Google Scholar
• MacLean MR, Deuchar GA, Hicks MN, Morecroft I, Shen S, Sheward J, Colston J, Loughlin L, Nilsen M, Dempsie Y, et al. Overexpression of the 5-hydroxytryptamine transporter gene: effect on pulmonary hemodynamics and hypoxia-induced pulmonary hypertension. Circulation 2004; 109:2150-5; PMID:15078799; http://dx.doi.org/10.1161/01.CIR.0000127375.56172.92
   PubMed Web of Science ®Google Scholar
• White K, Dempsie Y, Nilsen M, Wright AF, Loughlin L, MacLean MR. The serotonin transporter, gender, and 17β estradiol in the development of pulmonary arterial hypertension. Cardiovasc Res 2011; 90:373-82; PMID:21177701; http://dx.doi.org/10.1093/cvr/cvq408
   PubMed Web of Science ®Google Scholar
• Dempsie Y, Nilsen M, White K, Mair KM, Loughlin L, Ambartsumian N, Rabinovitch M, Maclean MR. Development of pulmonary arterial hypertension in mice over-expresssing S100A4/Mts1 is specific to females. Respir Res 2011; 12:159; PMID:22185646; http://dx.doi.org/10.1186/1465-9921-12-159
   PubMed Web of Science ®Google Scholar
• Dempsie Y, Morecroft I, Welsh DJ, MacRitchie NA, Herold N, Loughlin L, Nilsen M, Peacock AJ, Harmar A, Bader M, et al. Converging evidence in support of the serotonin hypothesis of dexfenfluramine-induced pulmonary hypertension with novel transgenic mice. Circulation 2008; 117:2928-37; PMID:18506000; http://dx.doi.org/10.1161/CIRCULATIONAHA.108.767558
   PubMed Web of Science ®Google Scholar
• Launay J-M, Hervé P, Peoc'h K, Tournois C, Callebert J, Nebigil CG, Etienne N, Drouet L, Humbert M, Simonneau G, et al. Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Nature Medicine 2002; 8:1129-35; PMID:12244304; http://dx.doi.org/10.1038/nm764
   PubMed Web of Science ®Google Scholar
• Tao R, Fray A, Aspley S, Brammer R, Heal D, Averbach S. Effects on serotonin in rat hypothalamus of D-fenfluramine, aminorex, phentermine and fluoxetine. Eur J Pharmacol 2002; 445:69-81; PMID:12065196; http://dx.doi.org/10.1016/S0014-2999(02)01751-X
   PubMed Web of Science ®Google Scholar
• Prow MR, Lancashire B, Aspley S, Heal DJ, Kilpatrick IC. Additive effects on rat brain 5HT release of combining phentermine with dexfenfluramine. Int J Obes Relat Metab Disord 2001; 25:145-1453; http://dx.doi.org/10.1038/sj.ijo.0801717
   Web of Science ®Google Scholar
• Jia Y, El-Haddad M, Gendy A, Nguyen T, Ross MG. Serotonin-induced region-specific responses of the arcuate nucleus and ventromedial hypothalamic nuclei. Int J Neurosci 2010; 120:386-95; PMID:20402579; http://dx.doi.org/10.3109/00207450802336683
   PubMed Web of Science ®Google Scholar
• Voigt JP, Fink H. Serotonin controlling feeding and satiety. Behave Brain Res 2015; 277:14-31; http://dx.doi.org/10.1016/j.bbr.2014.08.065
   PubMed Web of Science ®Google Scholar
• Argenio GF, Bernini GP, Sgró M, Vivaldi MS, Del  , Corso C, Santoni R, Franchi F. Blunted growth hormone (GH) responsiveness to GH-releasing hormone in obese patients: influence of prolonged administration of serotoninergic drug fenfluramine. Metabolism 1991; 40:724-7; PMID:1870427; http://dx.doi.org/10.1016/0026-0495(91)90091-A
   PubMed Web of Science ®Google Scholar
• Lee JY, Muenzberg H, Gavrilova O, Reed JA, Berryman D, Villanueva EC, Louis GW, Leinninger GM, Bertuzzi S, Seeley RJ, et al. Loss of cytokine-STAT5 signaling in the CNS and pituitary gland alters energy balance and leads to obesity. PLoS One 2008; 3:e1639; PMID:18286195; http://dx.doi.org/10.1371/journal.pone.0001639
   PubMedGoogle Scholar
• Chiba T, Kimura S, Takahashi K, Morimoto Y, Sanbe A, Ueda H, Kudo K. Serotonin suppresses β-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A. Biol Pharm Bull 2014; 37:1336-40; PMID:25087955; http://dx.doi.org/10.1248/bpb.b14-00273
   PubMed Web of Science ®Google Scholar
• Lieberman LA, Higgins DE. A small-molecule screen identifies the antipsychotic drug pimozide as an inhibitor of Listeria monocytogenes infection. Antimicrob Agents Chemother 2009; 53:756-64; PMID:19015342; http://dx.doi.org/10.1128/AAC.00607-08
   PubMed Web of Science ®Google Scholar
• Nelson EA, Walker SR, Weisberg E, Bar-Natan M, Barrett R, Gashin LB, Terrell S, Klitgaard JL, Santo L, Addorio MR, et al. The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors. Blood 2011; 117:3421-09; PMID:21233313; http://dx.doi.org/10.1182/blood-2009-11-255232
   PubMed Web of Science ®Google Scholar
• Yee KW, O'Farrell AM, Smolich BD, Cherrington JM, McMahon G, Wait CL, McGreevey LS, Griffith DJ, Heinrich MC. SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinase. Blood 2002; 100:2941-9; PMID:12351406; http://dx.doi.org/10.1182/blood-2002-02-0531
   PubMed Web of Science ®Google Scholar
• Roskovski R, Jr. Sunitinib: a VEGF and PDGF receptor protein kinase and angiogenesis inhibitor. Biochem Biophys Res Commun 2007; 356:323-8; PMID:17367763; http://dx.doi.org/10.1016/j.bbrc.2007.02.156
   PubMed Web of Science ®Google Scholar
• Mezrich JD, Nguyen LP, Kennedy G, Nukaya M, Fechner JH, Zhang X, Xing Y, Bradfield CA. SU5416, a VEGF receptor inhibitor and ligand of the AHR represents a new alternative for immunomodulation. PLoS One 2012; 7(9):e44547; PMID:22970246; http://dx.doi.org/10.1371/journal.pone.0044547
   PubMed Web of Science ®Google Scholar
• Jara A, Benner CM, Sim D, Liu X, List EO, Householder LA, Berryman DE, Kopchik JJ. Elevated systolic blood pressure in male GH transgenic mice is age dependent. Endocrinology 2014; 155:975-86; PMID:24424040; http://dx.doi.org/10.1210/en.2013-1899
   PubMed Web of Science ®Google Scholar
• Frantz AG, Rabkin MT. Effects of estrogen and sex difference on secretion of human growth hormone. J Clin Endocr 1965; 25:1470-80; PMID:5843702; http://dx.doi.org/10.1210/jcem-25-11-1470
   PubMed Web of Science ®Google Scholar
• Yang YM, Huang A, Kaley G, Sun D. eNOS uncoupling and endothelial dysfunction in aged vessels. Am J Physiol Heart Circ Physiol 2009; 297:H1829-1836; PMID:19767531; http://dx.doi.org/10.1152/ajpheart.00230.2009
   PubMed Web of Science ®Google Scholar